Ari S. Kellen

2014

In 2014, Ari S. Kellen earned a total compensation of $50.6M as Executive Vice President, Company Group Chairman at Valeant Pharmaceuticals International.

Compensation breakdown

Bonus$5,000,000
Non-Equity Incentive Plan$1,800,000
Salary$752,885
Stock Awards$43,085,254
Other$2,521
Total$50,640,660

Kellen received $43.1M in stock awards, accounting for 85% of the total pay in 2014.

Kellen also received $5M in bonus, $1.8M in non-equity incentive plan, $752.9K in salary and $2.5K in other compensation.

Rankings

In 2014, Ari S. Kellen's compensation ranked 19th out of 13,032 executives tracked by ExecPay. In other words, Kellen earned more than 99.9% of executives.

ClassificationRankingPercentile
All
19
out of 13,032
100th
Division
Manufacturing
7
out of 4,967
100th
Major group
Chemicals And Allied Products
1
out of 1,690
100th
Industry group
Drugs
1
out of 1,369
100th
Industry
Pharmaceutical Preparations
1
out of 1,042
100th
Source: SEC filing on April 29, 2016.

Kellen's colleagues

We found six more compensation records of executives who worked with Ari S. Kellen at Valeant Pharmaceuticals International in 2014.

2014

Howard Schiller

Valeant Pharmaceuticals International

Chief Financial Officer

2014

Robert Chai-Onn

Valeant Pharmaceuticals International

Chief Legal Officer

2014

Pavel Mirovsky

Valeant Pharmaceuticals International

President and General Manager, Europe

2014

J Pearson

Valeant Pharmaceuticals International

Chief Executive Officer

2014

Debora Jorn

Valeant Pharmaceuticals International

Group Chairman

2014

Brian Stolz

Valeant Pharmaceuticals International

Senior Vice President and General Manager

You may also like